A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring

Continuous glucose monitoring (CGM) can help improve blood sugar management in type 2 diabetes. A sequential, multiple assignment, randomized trial will evaluate clinical pharmacists, community health workers, and telehealth in supporting CGM use to improve blood sugar control.

Inclusion Criteria: * Age 25-75. * History of T2DM \> 1 year. * Speak English or Spanish. * A1c ≥ 8% (within past 6 months) - with reduction if necessary based on recruitment. * eGFR (estimated glomerular filtration rate) \> 30. * Willingness to use continuous glucose monitoring (CGM) and work with a community health worker (including home visits) and clinical pharmacist. Exclusion Criteria: * Plans for weight reduction surgery or prescription weight loss medication (specific for weight loss, not GLP-1). * Current, recent, or planned use of CGM. * Current use of steroids. * Abuse of illicit drugs. * Pregnancy (or planned pregnancy). * Specific comorbidities (e.g., recent MI, TIA, CVA, malignancy, hemoglobinopathy, severe hypoglycemia, etc.). * Psychiatric disorder that may limit ability to perform study tasks * Skin changes that preclude use of sensor or allergy to adhesive. * Planning to leave geographic area within 12 months or distance from clinical site \> 20 miles. * Participation in another study.